Mod­er­na near­ing deal with US gov­ern­ment to de­vel­op Ebo­la vac­cines — re­port

The biggest pan­dem­ic biotech dar­ling is re­port­ed­ly one step clos­er to se­cur­ing a new deal for oth­er se­ri­ous in­fec­tious dis­eases.

Mod­er­na is near­ing an agree­ment with the US gov­ern­ment to de­vel­op vac­cines for Ebo­la and ad­di­tion­al virus­es con­sid­ered to be threats, Bloomberg re­port­ed Wednes­day. The deal is ex­pect­ed to see Mod­er­na work with re­searchers from the Uni­ver­si­ty of Texas Med­ical Branch at Galve­ston to em­u­late its rapid ap­proach to Covid-19 for such virus­es.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER